An evaluation of two novel capillaroscopy techniques in suspected scleroderma-spectrum disorders: A single-centre cross-sectional study
Sign Up to like & getrecommendations! Published in 2018 at "Modern Rheumatology"
DOI: 10.1080/14397595.2017.1404179
Abstract: Abstract Objectives: The primary aim was to evaluate the diagnostic performance of digital photographs taken with a smartphone camera using both a lens attachment and, separately, a dermatoscope. The secondary aims were to assess the… read more here.
Keywords: capillaroscopy; spectrum disorders; microscopy; scleroderma spectrum ... See more keywords
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders
Sign Up to like & getrecommendations! Published in 2020 at "Disease Markers"
DOI: 10.1155/2020/2696173
Abstract: Background Few biomarkers are available for early identification of pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) in systemic sclerosis (SS) and scleroderma spectrum disorders (SSD). Aims To evaluate Gas6, sAxl, and sMer as… read more here.
Keywords: spectrum disorders; sclerosis scleroderma; systemic sclerosis; pah ... See more keywords
Nailfold capillaroscopy for the early diagnosis of the scleroderma spectrum of diseases in patients without Raynaud’s phenomenon
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Scleroderma and Related Disorders"
DOI: 10.1177/23971983221088460
Abstract: Background: The utility of nailfold capillaroscopy in the evaluation of patients without Raynaud’s phenomenon is unclear. Objective: This study aims to compare the utility of nailfold capillaroscopy for the early diagnosis of the scleroderma-spectrum of… read more here.
Keywords: raynaud phenomenon; nailfold capillaroscopy; scleroderma spectrum; spectrum diseases ... See more keywords
Use of intravenous epoprostenol as a treatment for the digital vasculopathy associated with the scleroderma spectrum of diseases
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Scleroderma and Related Disorders"
DOI: 10.5301/jsrd.5000255
Abstract: Introduction Intravenous prostanoid therapy is recommended for severe systemic sclerosis-related digital vasculopathy. The evidence supporting this recommendation is limited. The aim of this study was to evaluate the safety and efficacy of treating scleroderma spectrum… read more here.
Keywords: spectrum digital; digital vasculopathy; intravenous epoprostenol; epoprostenol infusion ... See more keywords